Developer docs
API playgroundTry for free, no card

Search company profiles

dna Communications

Full company profile

uuid000csi4

Namestring
dna Communications
Legal namestring
DNA Communications
Websiteurl
dna-comms.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

dna Communications is a healthcare-focused B2B public relations and scientific communications agency founded in 2007 and headquartered in New York. The firm serves pharmaceutical companies, biotechnology innovators, and healthcare brands, providing integrated services across five functional pillars: Scientific Communications, Strategy, Creative, Media Relations, and Integrated Media. Its core proposition is translating complex scientific and clinical information into narratives that drive understanding and behavior change among patients, healthcare professionals, and policymakers. The agency operates a global delivery footprint with eight offices across four regions — New York, Chicago, and Boston in the Americas; London, Cologne, and Frankfurt in EMEA; Hong Kong in APAC; and São Paulo in LATAM — enabling region-local execution for multinational clients.

The agency's most significant recent product initiative is dnaHelix, a dedicated global strategic communications support offering for biotech companies launched in November 2025. Beyond dnaHelix, revenue is generated through custom, negotiated professional services engagements with enterprise healthcare clients; pricing is not publicly disclosed and is consistent with quote-based, project-and-retainer structures typical of healthcare PR agencies. The firm's go-to-market is enterprise field sales targeting large pharma, biotech, and healthcare brand buyers. Internally, the senior leadership team includes Mike Rosich (CEO), Sara Baker (General Manager, Head of North America), Sandra Wagner (Senior Vice President and Head of Germany), and Candice Hardie (Vice President), supported by discipline leads across Scientific Communications, Strategy, Creative, Media Relations, and Integrated Media.

The business operates as a privately held agency with no disclosed parent company, institutional investors, or external funding. The ownership structure is not publicly disclosed, but the absence of funding data, M&A activity, or public listing references is consistent with an independent, bootstrapped professional services firm. The company has accumulated industry recognition including the 2025 MM+M Agency 100 designation, MM+M Agency of the Year (Silver), MM+M Gold Award, Clio Health Silver, PRovoke Media Sabre Award North America, PRNews Top 100 and Top 120 Agency Elite listings, and PRWeek Best Places to Work (midsize agency, 2024), positioning it as a credible mid-tier healthcare communications partner globally.

Short descriptiontext

dna Communications is a privately held healthcare communications and public relations agency founded in 2007, serving pharmaceutical, biotechnology, and healthcare brand clients globally through eight offices across the Americas, EMEA, APAC, and LATAM.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare communications, scientific communications, medical PR agency, biotech communications, health marketing
Industry1 code
PRIMARYMPAAADAC
Technology & B2B PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies
NAICS code1 code
  • Public Relations Agencies54182
Product category
Healthcare Communications Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Communications Services
TypeProfessional Services
Description

DNA Communications generates revenue through professional services engagements as a healthcare communications and PR agency, providing scientific communications, strategy, creative, media relations, and integrated media services to healthcare innovators and brands.

dnacommunications.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1dnaHelix
Description

Global strategic communications support for biotechs

dnacommunications.com
Core offering1 text field

dna Communications is a B2B healthcare communications and PR agency that provides scientific communications, strategy, creative, media relations, and integrated media services to pharmaceutical companies, biotech innovators, and healthcare brands. The agency operates specialized teams under a unified philosophy focused on translating complex scientific breakthroughs into meaningful health impact, and has launched dnaHelix as a dedicated global strategic communications support service for biotech companies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

dna Communications is a healthcare communications and PR agency offering a unified service portfolio centered on scientific communications, strategy, creative, media relations, and integrated media. The agency recently launched dnaHelix as a dedicated global strategic communications support service for biotech companies. The core offering consists of specialized teams (Scientific Communications, Strategy, Creative, Media Relations, Integrated Media) working collaboratively under a unified philosophy focused on meaningful science and meaningful insights.

Product and service1 record
1dnaHelix
CategoryBiotech Communications Service
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare-specialist public relations agency serving pharmaceutical, biotech, and consumer health clients with comparable scientific communications and patient-focused messaging offerings.

TypeBroad incumbent
Description

World's largest PR firm with a substantial healthcare and biotech practice serving global pharmaceutical clients, frequently competing against midsize specialists on enterprise pitches.

TypeBroad incumbent
Description

Large CRO/communications platform with healthcare public relations and medical communications capabilities, offering broader clinical-commercial integration than DNA Communications.

TypeDirect peer
Description

Healthcare consultancy with integrated communications offerings, serving biopharma clients globally with comparable scientific and brand communications expertise.

TypeBroad incumbent
Description

Global PR agency with a health practice providing scientific storytelling, media relations, and integrated campaigns to pharmaceutical, biotech, and health-system clients.

TypeDirect peer
Description

Healthcare-focused communications and marketing agency serving pharma and biotech clients with a similar integrated scientific communications model.

TypeBroad incumbent
Description

Global PR network with a dedicated healthcare practice serving pharma, biotech, and consumer health clients; competes for large enterprise healthcare communications mandates.

TypeDirect peer
Description

Long-standing healthcare-focused PR firm now operating inside the Evoke network, historically serving biotech specialty pharma with similar scientific narrative positioning.

TypeBroad incumbent
Description

Global communications agency with a deep healthcare and life-sciences practice offering media relations, scientific communications, and integrated marketing to pharma clients.

10Evoke (Ashfield Health)
TypeDirect peer
Description

Specialized healthcare communications and public relations agency operating within a global health-adjacent network, directly competitive with DNA Communications on biotech and pharma accounts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

dna Communications

Healthcare Communications Servicesdna-comms.com

dna Communications is a privately held healthcare communications and public relations agency founded in 2007, serving pharmaceutical, biotechnology, and healthcare brand clients globally through eight offices across the Americas, EMEA, APAC, and LATAM.

What dna Communications does

dna Communications is a healthcare-focused B2B public relations and scientific communications agency founded in 2007 and headquartered in New York. The firm serves pharmaceutical companies, biotechnology innovators, and healthcare brands, providing integrated services across five functional pillars: Scientific Communications, Strategy, Creative, Media Relations, and Integrated Media. Its core proposition is translating complex scientific and clinical information into narratives that drive understanding and behavior change among patients, healthcare professionals, and policymakers. The agency operates a global delivery footprint with eight offices across four regions — New York, Chicago, and Boston in the Americas; London, Cologne, and Frankfurt in EMEA; Hong Kong in APAC; and São Paulo in LATAM — enabling region-local execution for multinational clients.

The agency's most significant recent product initiative is dnaHelix, a dedicated global strategic communications support offering for biotech companies launched in November 2025. Beyond dnaHelix, revenue is generated through custom, negotiated professional services engagements with enterprise healthcare clients; pricing is not publicly disclosed and is consistent with quote-based, project-and-retainer structures typical of healthcare PR agencies. The firm's go-to-market is enterprise field sales targeting large pharma, biotech, and healthcare brand buyers. Internally, the senior leadership team includes Mike Rosich (CEO), Sara Baker (General Manager, Head of North America), Sandra Wagner (Senior Vice President and Head of Germany), and Candice Hardie (Vice President), supported by discipline leads across Scientific Communications, Strategy, Creative, Media Relations, and Integrated Media.

The business operates as a privately held agency with no disclosed parent company, institutional investors, or external funding. The ownership structure is not publicly disclosed, but the absence of funding data, M&A activity, or public listing references is consistent with an independent, bootstrapped professional services firm. The company has accumulated industry recognition including the 2025 MM+M Agency 100 designation, MM+M Agency of the Year (Silver), MM+M Gold Award, Clio Health Silver, PRovoke Media Sabre Award North America, PRNews Top 100 and Top 120 Agency Elite listings, and PRWeek Best Places to Work (midsize agency, 2024), positioning it as a credible mid-tier healthcare communications partner globally.

dna Communications firmographics

Firmographics
Name
dna Communications
Legal name
DNA Communications
Website
https://dna-comms.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
101–250 employees
Short description
dna Communications is a privately held healthcare communications and public relations agency founded in 2007, serving pharmaceutical, biotechnology, and healthcare brand clients globally through eight offices across the Americas, EMEA, APAC, and LATAM.
Ownership category
akta.pro rank

dna Communications industry classification

Industry
Product category
Healthcare Communications Services
NAICS
Public Relations Agencies (54182)
akta.pro industry
PRIMARYMPAAADAC
Technology & B2B PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies

Keywords

  • Healthcare communications
  • Scientific communications
  • Medical PR agency
  • Biotech communications
  • Health marketing

Where dna Communications is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices8 records

Markets served

dna Communications business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Healthcare Communications Services: DNA Communications generates revenue through professional services engagements as a healthcare communications and PR agency, providing scientific communications, strategy, creative, media relations, and integrated media services to healthcare innovators and brands.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

dna Communications product offering

Product offering

Core offering

dna Communications is a B2B healthcare communications and PR agency that provides scientific communications, strategy, creative, media relations, and integrated media services to pharmaceutical companies, biotech innovators, and healthcare brands. The agency operates specialized teams under a unified philosophy focused on translating complex scientific breakthroughs into meaningful health impact, and has launched dnaHelix as a dedicated global strategic communications support service for biotech companies.

Product overview

dna Communications is a healthcare communications and PR agency offering a unified service portfolio centered on scientific communications, strategy, creative, media relations, and integrated media. The agency recently launched dnaHelix as a dedicated global strategic communications support service for biotech companies. The core offering consists of specialized teams (Scientific Communications, Strategy, Creative, Media Relations, Integrated Media) working collaboratively under a unified philosophy focused on meaningful science and meaningful insights.

Differentiator

Problem solved

Functional benefit

Brands

  • dnaHelix: Global strategic communications support for biotechs

Products and services

  • dnaHelix

Companies that use dna Communications

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

dna Communications technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

dna Communications partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

dna Communications competitors and assessment

Company assessment

Direct peers

  • GCI Health: Healthcare-specialist public relations agency serving pharmaceutical, biotech, and consumer health clients with comparable scientific communications and patient-focused messaging offerings.
  • Avalere Health (Fishawack): Healthcare consultancy with integrated communications offerings, serving biopharma clients globally with comparable scientific and brand communications expertise.
  • Real Chemistry: Healthcare-focused communications and marketing agency serving pharma and biotech clients with a similar integrated scientific communications model.
  • Chamberlain Healthcare PR (now within Evoke): Long-standing healthcare-focused PR firm now operating inside the Evoke network, historically serving biotech specialty pharma with similar scientific narrative positioning.
  • Evoke (Ashfield Health): Specialized healthcare communications and public relations agency operating within a global health-adjacent network, directly competitive with DNA Communications on biotech and pharma accounts.

Broad incumbents

  • Edelman (Health): World's largest PR firm with a substantial healthcare and biotech practice serving global pharmaceutical clients, frequently competing against midsize specialists on enterprise pitches.
  • Syneos Health Communications: Large CRO/communications platform with healthcare public relations and medical communications capabilities, offering broader clinical-commercial integration than DNA Communications.
  • Ketchum (Health): Global PR agency with a health practice providing scientific storytelling, media relations, and integrated campaigns to pharmaceutical, biotech, and health-system clients.
  • Weber Shandwick (Healthcare Practice): Global PR network with a dedicated healthcare practice serving pharma, biotech, and consumer health clients; competes for large enterprise healthcare communications mandates.
  • FleishmanHillard (Healthcare): Global communications agency with a deep healthcare and life-sciences practice offering media relations, scientific communications, and integrated marketing to pharma clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

dna Communications social profiles

Digital presence

dna Communications financial estimates

Financial estimate

Revenue estimate

Valuation estimate

dna Communications leadership team

Management profile

Number of profiles

Profiles9 records

dna Communications funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

dna Communications M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about dna Communications

What does dna Communications do?

dna Communications is a B2B healthcare communications and PR agency that provides scientific communications, strategy, creative, media relations, and integrated media services to pharmaceutical companies, biotech innovators, and healthcare brands. The agency operates specialized teams under a unified philosophy focused on translating complex scientific breakthroughs into meaningful health impact, and has launched dnaHelix as a dedicated global strategic communications support service for biotech companies.

Is dna Communications a public or private company?

dna Communications is a private company. It is classified as unknown and is currently operating.

When was dna Communications founded?

dna Communications was founded in 2007. It employs 101 to 250 people.

Where is dna Communications based?

dna Communications is headquartered in New York, United States, in the North America region.

How does dna Communications make money?

One revenue line is on record: healthcare Communications Services.

Who are dna Communications's main competitors?

Direct peers on record are GCI Health, Avalere Health (Fishawack), Real Chemistry, Chamberlain Healthcare PR (now within Evoke) and Evoke (Ashfield Health). Broad incumbents are Edelman (Health), Syneos Health Communications, Ketchum (Health), Weber Shandwick (Healthcare Practice) and FleishmanHillard (Healthcare).

Does dna Communications have an API?

No public API is recorded for dna Communications.

What industry is dna Communications in?

dna Communications's product category is Healthcare Communications Services. Its primary akta.pro industry code is MPAAADAC, Technology & B2B PR. Its NAICS code is 54182.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals